Itron (NASDAQ:ITRI) Issues Q1 2026 Earnings Guidance

Itron (NASDAQ:ITRI) issued an update on its first quarter 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 1.200-1.300 for the period, compared to the consensus earnings per share estimate of 1.360. The company issued revenue guidance of $565.0 million-$575.0 million, compared to the consensus revenue estimate of $593.0 million. Itron also updated its FY 2026 guidance to 5.750-6.250 EPS.

Itron Stock Up 7.9%

Shares of NASDAQ ITRI traded up $7.07 during mid-day trading on Tuesday, reaching $96.43. 2,764,159 shares of the company traded hands, compared to its average volume of 689,212. The company’s fifty day moving average is $97.61 and its two-hundred day moving average is $110.66. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.91 and a current ratio of 2.17. Itron has a fifty-two week low of $88.57 and a fifty-two week high of $142.00. The stock has a market cap of $4.42 billion, a PE ratio of 17.34, a price-to-earnings-growth ratio of 0.51 and a beta of 1.48.

Itron (NASDAQ:ITRI) last announced its earnings results on Tuesday, February 17th. The scientific and technical instruments company reported $2.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.19 by $0.27. Itron had a return on equity of 17.82% and a net margin of 10.69%.The firm had revenue of $571.66 million during the quarter, compared to analysts’ expectations of $561.31 million. During the same quarter in the prior year, the business earned $1.35 earnings per share. The company’s revenue was down 6.7% on a year-over-year basis. Itron has set its Q1 2026 guidance at 1.200-1.300 EPS and its FY 2026 guidance at 5.750-6.250 EPS. On average, analysts expect that Itron will post 5.33 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on ITRI shares. Wall Street Zen downgraded shares of Itron from a “buy” rating to a “hold” rating in a report on Wednesday, January 14th. Oppenheimer dropped their price objective on Itron from $145.00 to $125.00 and set an “outperform” rating on the stock in a research note on Tuesday, January 27th. Robert W. Baird reissued a “neutral” rating and set a $118.00 price objective (down previously from $137.00) on shares of Itron in a research report on Friday, October 31st. Argus reaffirmed a “hold” rating on shares of Itron in a report on Tuesday, November 4th. Finally, Stephens raised Itron from an “equal weight” rating to an “overweight” rating and set a $130.00 price target on the stock in a research report on Monday, November 3rd. Seven research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Itron presently has a consensus rating of “Hold” and an average target price of $136.10.

Insider Transactions at Itron

In related news, SVP John F. Marcolini sold 553 shares of the company’s stock in a transaction on Monday, November 24th. The stock was sold at an average price of $96.51, for a total value of $53,370.03. Following the completion of the transaction, the senior vice president directly owned 13,843 shares in the company, valued at approximately $1,335,987.93. This represents a 3.84% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, SVP Donald L. Reeves III sold 536 shares of the firm’s stock in a transaction on Monday, November 24th. The stock was sold at an average price of $96.51, for a total value of $51,729.36. Following the completion of the transaction, the senior vice president directly owned 19,068 shares of the company’s stock, valued at approximately $1,840,252.68. This trade represents a 2.73% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders have sold 3,113 shares of company stock worth $301,678. 1.51% of the stock is currently owned by company insiders.

Key Itron News

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Q4 beat and strong guidance — Itron reported non‑GAAP EPS of $2.46 (beat) and revenue above estimates; management gave Q1 2026 and full‑year 2026 revenue and non‑GAAP EPS ranges that imply growth and continued margin improvement, which is a primary driver of the stock move. Itron shares rise after Q4 profit surge, strong cash flow, and 2026 outlook
• Positive Sentiment: Margins and cash flow improved — GAAP gross margin expanded ~560 bps to ~40.5% and Q4 free cash flow was ~$112M (FY FCF ~$383M), signaling operating leverage that supports higher EPS and buyback/strategic investment optionality. Itron (ITRI) Reports Q4 Earnings: What Key Metrics Have to Say
• Positive Sentiment: Recurring revenue strategy and M&A — Itron closed the Locusview deal (and earlier Urbint) to accelerate software and recurring‑revenue mix; management commentary tied this strategy to future margin resilience and higher lifetime value. Backlog also stands at ~$4.5B. Itron Announces Fourth Quarter and Full Year 2025 Financial Results
• Neutral Sentiment: Full materials and commentary available — Earnings call transcript and slide deck provide details for modeling revenue mix, margin cadence, and FCF conversion; useful for investors refining estimates. Itron, Inc. (ITRI) Q4 2025 Earnings Call Transcript
• Negative Sentiment: Booking and regulatory headwinds noted — Some investor letters and coverage flagged softer-than-expected bookings and slower regulatory approvals in Q4, which could pressure near‑term revenue cadence despite margin gains. Softer Than Expected Booking Hurt Itron’s (ITRI) Shares in Q4
• Negative Sentiment: Insider selling — Recent disclosures show multiple insider sales over the last six months; heavy selling can be perceived negatively by some investors. Itron shares rise after Q4 profit surge, strong cash flow, and 2026 outlook

Institutional Trading of Itron

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ITRI. Lido Advisors LLC raised its stake in shares of Itron by 6.1% in the fourth quarter. Lido Advisors LLC now owns 2,672 shares of the scientific and technical instruments company’s stock valued at $248,000 after acquiring an additional 154 shares during the last quarter. CIBC Asset Management Inc increased its holdings in Itron by 71.5% during the 4th quarter. CIBC Asset Management Inc now owns 2,801 shares of the scientific and technical instruments company’s stock valued at $260,000 after purchasing an additional 1,168 shares in the last quarter. Wexford Capital LP bought a new position in Itron in the 3rd quarter valued at $276,000. Banque Cantonale Vaudoise boosted its stake in Itron by 232.7% in the third quarter. Banque Cantonale Vaudoise now owns 905 shares of the scientific and technical instruments company’s stock worth $113,000 after purchasing an additional 633 shares in the last quarter. Finally, State of Wyoming bought a new stake in shares of Itron during the second quarter worth $214,000. Institutional investors own 96.19% of the company’s stock.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.